BIOV — BioVersys AG Share News
0.000.00%
HealthcareSpeculativeSmall Cap
- CH₣158.07m
- CH₣179.80m
- CH₣0.80m
RCS - Bio Versys AG - BioVersys and partners’
Brief: BioVersys Announces BV100 Phase 3 Initiation And Provides Business Update
Brief: Bioversys Says Patent Claims For Its BV100 Drug Candidate Have Been Granted In China
UBS, Stifel start coverage of BioVersys with 'buy;' shares climb
UBS starts coverage of BioVersys with 'buy;' shares climb
Brief: BioVersys Announces Partial Exercise Of Over-Allotment Option
Swiss biotech Bioversys' shares open slightly higher on stock market debut